- Home
- ONCO vs DOMH Comparison
ONCO vs DOMH Comparison
Compare ONCO & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCO
- DOMH
- Stock Information
- Founded
- ONCO 2018
- DOMH 1967
- Country
- ONCO United States
- DOMH United States
- Employees
- ONCO N/A
- DOMH N/A
- Industry
- ONCO Biotechnology: Pharmaceutical Preparations
- DOMH Biotechnology: Pharmaceutical Preparations
- Sector
- ONCO Health Care
- DOMH Health Care
- Exchange
- ONCO Nasdaq
- DOMH Nasdaq
- Market Cap
- ONCO 1.8M
- DOMH 94.0M
- IPO Year
- ONCO 2022
- DOMH N/A
- Fundamental
- Price
- ONCO $3.22
- DOMH $6.07
- Analyst Decision
- ONCO
- DOMH
- Analyst Count
- ONCO 0
- DOMH 0
- Target Price
- ONCO N/A
- DOMH N/A
- AVG Volume (30 Days)
- ONCO 47.5K
- DOMH 304.5K
- Earning Date
- ONCO 08-14-2025
- DOMH 11-07-2025
- Dividend Yield
- ONCO N/A
- DOMH 8.91%
- EPS Growth
- ONCO N/A
- DOMH N/A
- EPS
- ONCO N/A
- DOMH N/A
- Revenue
- ONCO $1,326,959.00
- DOMH $52,811,000.00
- Revenue This Year
- ONCO N/A
- DOMH N/A
- Revenue Next Year
- ONCO N/A
- DOMH N/A
- P/E Ratio
- ONCO N/A
- DOMH N/A
- Revenue Growth
- ONCO N/A
- DOMH 455.38
- 52 Week Low
- ONCO $2.61
- DOMH $0.83
- 52 Week High
- ONCO $552.50
- DOMH $13.58
- Technical
- Relative Strength Index (RSI)
- ONCO 54.28
- DOMH 52.78
- Support Level
- ONCO $3.00
- DOMH $5.61
- Resistance Level
- ONCO $3.32
- DOMH $7.18
- Average True Range (ATR)
- ONCO 0.16
- DOMH 0.37
- MACD
- ONCO 0.08
- DOMH -0.37
- Stochastic Oscillator
- ONCO 84.56
- DOMH 85.24
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
About DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.